CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh
Clin Mol Hepatol. 2017;23(4):331-339.   Published online 2017 September 26    DOI: https://doi.org/10.3350/cmh.2016.0040

Excel Download

Su1414 A Randomized Controlled Trial to Compare the Efficacy and Safety of Entecavir Versus Tenofovir Treatment in Naïve Chronic Hepatitis B Patients
Gastroenterology. 2015;148(4):S-502   Crossref logo
Link1 Link2

Mo1833 Efficacy and Safety of Entecavir Versus Tenofovir Treatment in Chronic Hepatitis B Patients: A Randomized Controlled Trial
Gastroenterology. 2012;142(5):S-695   Crossref logo
Link1 Link2

Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
Clinical and Molecular Hepatology. 2017;23(4):331-339   Crossref logo
Link1 Link2 Link3

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial
Hepatology Research. 2016;47(3):E161-E168   Crossref logo
Link1 Link2 Link3

Entecavir Versus Lamivudine for Patients With HBeAg-Negative Chronic Hepatitis B
Yearbook of Pediatrics. 2007;2007:276-278   Crossref logo
Link1 Link2

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
Yearbook of Medicine. 2007;2007:80-81   Crossref logo
Link1 Link2

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
Yearbook of Gastroenterology. 2007;2007:253-255   Crossref logo
Link1 Link2

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis BB
Hepatology. 1999;29(3):889-896   Crossref logo
Link1 Link2

Entecavir versus lamivudine for HBeAg positive and negative chronic hepatitis B
Journal of Hepatology. 2006;45(3):457-460   Crossref logo
Link1 Link2

Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: Randomized controlled trial in Japanese patients
Journal of Gastroenterology and Hepatology. 2008;23(9):1320-1326   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.